U.S. Luxury Stock News

NasdaqGS:GILT
NasdaqGS:GILTCommunications

Gilat Satellite Networks (NasdaqGS:GILT) Margin Gains Reinforce Bullish Earnings Narratives In Q1 2026

Gilat Satellite Networks (NasdaqGS:GILT) opened 2026 with Q1 revenue of US$110.5 million and basic EPS of US$0.07. This set the tone for how its growth story is feeding through to the bottom line. The company reported revenue of US$92.0 million and an EPS loss of US$0.11 in Q1 2025, compared to revenue of US$110.5 million and an EPS profit of US$0.07 in Q1 2026. Trailing 12 month EPS is US$0.50 on revenue of US$470.1 million, which points to earnings growth supported by wider net margins. For...
NYSE:AKA
NYSE:AKASpecialty Retail

AKA Brands Holding Q1 Loss Narrows Challenging Bearish Narratives On Persistent Unprofitability

a.k.a. Brands Holding (AKA) has opened 2026 with Q1 revenue of US$132.5 million and a reported loss of US$7.1 million, which translates to basic EPS of US$0.66 in the red. Over the past year, the company has seen trailing twelve month revenue sit at US$604.0 million with a loss of US$30.2 million, or basic EPS of US$2.81 in the red, setting a clear backdrop of continued unprofitability. For investors, the latest quarter keeps the spotlight firmly on margins and on whether the current profile...
NYSE:PSFE
NYSE:PSFEDiversified Financial

Paysafe (PSFE) Q1 Loss Deepens And Tests Bulls On Turnaround Narrative

Paysafe (PSFE) opened 2026 with Q1 revenue of US$442.7 million and a loss of US$36.5 million on a net income basis, which translated to basic EPS of a US$0.71 loss. Over the past five quarters, the company has seen revenue move from US$420.1 million in Q4 2024 to US$401 million in Q1 2025 and then to US$442.7 million in Q1 2026. Over the same period, basic EPS shifted from a profit of US$0.55 in Q4 2024 to losses of US$0.33 in Q1 2025 and US$0.71 in Q1 2026. For investors, the latest report...
NYSE:FLNG
NYSE:FLNGOil and Gas

Flex LNG (FLNG) Margin Compression Tests Bullish Fleet And Contract Narratives

FLEX LNG (NYSE:FLNG) opened 2026 with Q1 revenue of US$80.5 million and basic EPS of US$0.36, while trailing twelve month revenue came in at US$339.7 million with EPS of US$1.40. Over recent quarters the company has seen revenue move from US$88.4 million and EPS of US$0.35 in Q1 2025 to US$80.5 million and EPS of US$0.36 in Q1 2026, set against a trailing net profit margin of 22.3% compared with 29.1% a year earlier. This update therefore lands in the context of compressed profitability that...
NasdaqCM:IGIC
NasdaqCM:IGICInsurance

Will Softer Q1 2026 Earnings and EPS Compression Change International General Insurance Holdings' (IGIC) Narrative?

International General Insurance Holdings Ltd. has reported past first-quarter 2026 results, with revenue of US$125.7 million and net income of US$21.7 million, both lower than the same period a year earlier. The drop in diluted earnings per share from continuing operations to US$0.49 from US$0.59 highlights pressure on profitability despite the company’s diversified insurance portfolio. We’ll now examine how this earnings softness, particularly the year-over-year net income decline, may...
NasdaqGS:JACK
NasdaqGS:JACKHospitality

Jack In The Box (JACK) Same Restaurant Sales Decline Challenges Bullish Turnaround Narrative

Jack in the Box (JACK) opened Q2 2026 with total revenue of US$254.3 million and basic EPS of US$0.65, alongside net income excluding extra items of US$12.5 million, setting the tone for how its turnaround story is tracking. The company has seen quarterly revenue move between US$265.7 million and US$371.1 million over the past five reported periods, while basic EPS has ranged from US$0.30 to US$1.63. This gives investors a clear view of how earnings power has shifted through recent quarters...
NYSE:SI
NYSE:SIMedical Equipment

Shoulder Innovations (SI) Q1 Losses Deepen And Test Premium Growth Narrative

Shoulder Innovations (SI) opened Q1 2026 with revenue of about US$16.7 million and a basic EPS loss of US$0.41, against a backdrop of revenue growth reported at 55.9% over the past year and trailing twelve month EPS of a US$3.19 loss. Over recent quarters the company has seen revenue move from roughly US$10.1 million in Q1 2025 to US$16.7 million in Q1 2026, while quarterly EPS losses shifted from about US$52.13 to US$0.41, setting up a story of rapid top line expansion paired with margins...
NasdaqGS:KRNT
NasdaqGS:KRNTMachinery

Kornit Digital (KRNT) Q1 Loss Of US$8.2 Million Challenges Recurring Revenue Stability Narrative

Kornit Digital (NasdaqGS:KRNT) opened Q1 2026 with revenue of US$48.5 million and a basic EPS loss of US$0.19, alongside a quarterly net loss of US$8.2 million, setting a cautious tone for the latest update. Over recent periods the company has seen revenue move from US$60.7 million in Q4 2024 to US$58.9 million in Q4 2025 and then to US$48.5 million in Q1 2026. EPS has swung between a profit of US$0.05 and losses such as US$0.17 and US$0.19, which keeps the spotlight firmly on margin pressure...
NasdaqGS:VICR
NasdaqGS:VICRElectrical

Why Vicor (VICR) Is Up 11.2% After AI‑Driven Q1 Beat And Heavy Insider Selling

In early May 2026, Vicor reported strong first-quarter results tied to AI and data‑center power demand, while multiple executives and directors exercised stock options and sold shares, alongside JPMorgan disclosing a 6.2% passive stake. The combination of robust AI‑related momentum and heavy insider selling, with no insider purchases over the past year, is sharpening investor focus on how management views Vicor’s current valuation and risk‑reward balance. Against this backdrop of strong AI...
NYSE:AMTM
NYSE:AMTMProfessional Services

Amentum Holdings (AMTM) Q2 Margins Near 1% Test Bullish Earnings Rebound Narrative

Amentum Holdings (AMTM) has released its Q2 2026 results with revenue of US$3.5b and net income of US$54m, translating to basic EPS of US$0.22 for the quarter and trailing twelve month EPS of US$0.61. The company has seen quarterly revenue move between US$3.2b and US$3.9b over the past six reported periods, while quarterly basic EPS has ranged from US$0.02 to US$0.22. This sets up a picture of modest top line progress paired with gradually improving earnings power. For investors, the key...
NasdaqGS:ENTA
NasdaqGS:ENTABiotechs

Enanta Pharmaceuticals (ENTA) Q2 Loss Improvement Tests Bearish Profitability Narratives

Enanta Pharmaceuticals (ENTA) has just posted Q2 2026 results with revenue of US$17.2 million and a basic EPS loss of US$0.45, while trailing twelve month figures show revenue of US$69.2 million and a basic EPS loss of US$2.47. Over recent quarters the company has seen revenue move between US$14.9 million and US$18.6 million, with quarterly basic EPS losses ranging from roughly US$0.41 to US$1.06 and trailing twelve month net losses of US$62.0 million. For investors, the story this quarter is...
NasdaqGS:CMPS
NasdaqGS:CMPSBiotechs

Why COMPASS Pathways (CMPS) Is Up 13.1% After FDA Fast-Track Moves For COMP360 Profit Shift

In the first quarter of 2026, COMPASS Pathways reported net income of US$91.2 million, or US$0.71 per share, and announced U.S. FDA acceptance of a rolling New Drug Application and a National Priority Review Voucher for its COMP360 psilocybin therapy in treatment-resistant depression. This combination of an accounting-driven swing to profitability and accelerated regulatory review for COMP360 marks a key moment for COMPASS Pathways’ shift from pure R&D focus toward potential commercial...
NYSE:IBM
NYSE:IBMIT

A Look At IBM (IBM) Valuation As Shares Decline Despite Strong Multi Year Returns

Stock performance and business profile International Business Machines (IBM) has delivered mixed share performance recently, with the stock up about 91% over the past 3 years but down 25% year to date and 16% over the past year. At a recent close of US$218.37 and a market value of about US$201.7b, IBM sits among the larger US technology and services companies. It combines software, consulting, infrastructure and financing under one umbrella. The company reports annual revenue of US$68.9b and...
NasdaqGS:VEON
NasdaqGS:VEONWireless Telecom

VEON (NasdaqGS:VEON) Q1 EPS Leans On One Off Gain Challenging Earnings Quality Narratives

VEON (NasdaqGS:VEON) has opened 2026 with Q1 numbers that put the focus squarely on earnings quality, reporting US$1.2 billion in revenue and basic EPS of US$1.42, while trailing twelve month EPS sits at US$7.65 on revenue of US$4.6 billion. Over recent quarters the company has seen revenue move from US$998 million in Q4 2024 to US$1.03 billion in Q1 2025, US$1.09 billion in Q2 2025 and US$1.20 billion in Q1 2026, with quarterly EPS ranging from a loss of US$2.00 in Q3 2025 to US$8.50 in Q2...
NYSE:ENS
NYSE:ENSElectrical

Assessing EnerSys (ENS) Valuation After New Focus On Data Centers And Defense Power Systems

Why EnerSys is back in focus after its latest growth update EnerSys (ENS) has drawn fresh attention after outlining plans to expand in data centers and defense, including reallocating manufacturing capacity and steering its Greenville lithium facility toward drones and soldier power systems. See our latest analysis for EnerSys. The recent communications on AI infrastructure and defense electrification sit alongside very strong momentum, with a 30 day share price return of 20.45%, a year to...
NasdaqCM:QUIK
NasdaqCM:QUIKSemiconductor

QuickLogic (QUIK) Q1 Losses Persist Despite Higher Revenue Challenging Bullish Profitability Narratives

QuickLogic (QUIK) opened Q1 2026 with revenue of about US$5.1 million and a basic EPS loss of US$0.13, setting the tone for another quarter where the top line and per share results remain firmly in focus for investors who track the stock through earnings season. Over the past year, the company has reported quarterly revenue in a range of roughly US$2.0 million to US$5.7 million, while basic EPS has ranged from a small profit of about US$0.01 per share to a quarterly loss of about US$0.24 per...
NasdaqGS:PWP
NasdaqGS:PWPCapital Markets

How Investors May Respond To Perella Weinberg Partners (PWP) Profit Drop, Dividend Hold And Expanded CFO Role

Perella Weinberg Partners recently reported first-quarter 2026 results showing net income of US$1.49 million, down sharply from US$17.34 million a year earlier, while also affirming a quarterly dividend of US$0.07 per Class A share payable in June. Alongside the weaker quarter, the firm expanded Chief Financial Officer Alexandra Gottschalk’s remit to include Chief Operating Officer, highlighting a tighter focus on operational execution as management cited longer timelines to complete complex...
NasdaqGS:HAS
NasdaqGS:HASLeisure

Hasbro (HAS) Q1 Profit Challenges Ongoing Trailing Twelve Month Loss Narrative

Hasbro’s Q1 2026 earnings in focus Hasbro (HAS) opened 2026 with Q1 revenue of US$1,000.2 million and basic EPS of US$1.41, setting a clear snapshot of the business against a current share price of US$95.65. Over recent quarters the company has seen revenue move from US$887.1 million in Q1 2025 to US$1,000.2 million in Q1 2026, while basic EPS shifted from US$0.71 to US$1.41 over the same period. This gives investors a clearer look at how the top line and per share earnings are tracking. With...
NYSEAM:LCTX
NYSEAM:LCTXBiotechs

Lineage Cell Therapeutics (LCTX) Returns To Loss In Q1 2026 Challenging Profitability Narratives

Lineage Cell Therapeutics (LCTX) opened 2026 with Q1 revenue of US$1.7 million and a basic EPS loss of US$0.02, as net income excluding extraordinary items came in at a loss of US$4.8 million. The company has seen quarterly revenue move between US$1.5 million and US$6.6 million over the past year, while EPS has ranged from a loss of around US$0.13 per share to a small profit of US$0.00 per share, presenting a mixed picture regarding the path toward better margins. For investors, the latest...
NYSEAM:ESP
NYSEAM:ESPElectrical

Espey Mfg. & Electronics (ESP) Non Cash Heavy 25.5% Margin Challenges Bullish Earnings Narratives

Espey Mfg. & Electronics (ESP) has reported another solid set of Q3 2026 numbers, with revenue of about US$11.4 million and basic EPS of roughly US$1.03, supported by trailing 12 month EPS of US$3.95 on revenue of around US$42.2 million. The company has seen quarterly revenue range between US$9.1 million and US$13.6 million over the past six periods, while basic EPS has moved between US$0.66 and US$1.10. This sets up the latest quarter against a backdrop of higher trailing earnings growth and...
NasdaqGS:EYE
NasdaqGS:EYESpecialty Retail

National Vision Holdings (EYE) Margin Rebound To US$31.2 Million Net Income Tests Bearish Narratives

National Vision Holdings (EYE) opened 2026 with Q1 revenue of US$543.9 million and basic EPS of US$0.39, setting a clear marker for its latest quarter of trading. Over the past year, the company has seen trailing twelve month revenue reach about US$2.0 billion with basic EPS of US$0.59, compared with the prior trailing period’s revenue of US$1.99 billion and EPS of US$0.37. This gives investors a fuller view of how top line scale and per share profitability currently line up. Taken together,...
NYSE:USAC
NYSE:USACEnergy Services

USA Compression Partners (USAC) Is Up 6.9% After Q1 2026 Earnings Beat And Minimal Impairment Charge

USA Compression Partners, LP has already reported first-quarter 2026 results, with sales rising to US$309.4 million and net income to US$38.34 million, alongside basic and diluted earnings of US$0.27 per unit from continuing operations. An interesting aspect of the quarter was the very small US$4,000 non-cash impairment charge, sharply lower than the prior year’s US$3.65 million, which highlights a reduced need to mark down long-lived assets. Now we’ll examine how this strong revenue growth...
NasdaqGM:GHRS
NasdaqGM:GHRSPharmaceuticals

Assessing GH Research (GHRS) Valuation After New Shelf Registration And Follow On Equity Plan

Capital raising moves put GH Research in focus GH Research (GHRS) has filed a universal shelf registration of up to US$400 million across multiple securities, alongside a US$200 million at-the-market follow-on equity program for its ordinary shares. See our latest analysis for GH Research. The capital raising plans come after a strong run, with the share price at US$21.88 and a 30 day share price return of 33.9%. The 1 year total shareholder return of 119.24% and 3 year total shareholder...
NasdaqGM:IRMD
NasdaqGM:IRMDMedical Equipment

A Look At IRADIMED (IRMD) Valuation After Strong Q1 Results Dividend And Reaffirmed Guidance

What IRADIMED’s latest dividend and guidance mean for shareholders IRADIMED (IRMD) has drawn fresh attention after reporting first quarter results, reaffirming its 2026 earnings outlook, and declaring a regular quarterly dividend of $0.20 per share payable on May 29, 2026. See our latest analysis for IRADIMED. IRADIMED’s latest results and dividend decision have arrived as the share price has eased in recent months, with a 30 day share price return of 7.13% down and a 90 day return of 12.94%...